Literature DB >> 33402464

Effects of GGsTop® on Collagen and Glutathione in the Oral Mucosa Using a Rat Model of 5-Fluorouracil-Induced Oral Mucositis.

Issei Takeuchi1,2, Riko Kawamata1, Kimiko Makino3,2.   

Abstract

BACKGROUND/AIM: To evaluate the usefulness of GGsTop® for oral mucositis, a quantitative study focusing on oral mucosal tissues is necessary. In this study, we aimed to quantify collagen and glutathione using a rat model of 5-fluorouracil-induced oral mucositis.
MATERIALS AND METHODS: Changes in ulcer area and erythrocyte count were measured to confirm the usefulness of GGsTop® for oral mucositis. The effect of GGsTop on collagen was evaluated by observing oral mucosal tissue sections and measuring the collagen concentration in the tissues. The total glutathione concentration and the oxidized glutathione concentration were measured, and the concentration of the reduced form was calculated.
RESULTS: GGsTop® shortened the treatment period for oral mucositis without affecting the white blood cell count. In addition, GGsTop® promoted collagen production and alleviated oxidative stress conditions.
CONCLUSION: GGsTop affects collagen and glutathione in the treatment of oral mucositis. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  GGsTop®; Oral mucositis; collagen; glutathione

Mesh:

Substances:

Year:  2021        PMID: 33402464      PMCID: PMC7880782          DOI: 10.21873/invivo.12246

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  28 in total

Review 1.  Gamma-glutamyltransferase-dependent prooxidant reactions: a factor in multiple processes.

Authors:  Silvia Dominici; Aldo Paolicchi; Evelina Lorenzini; Emilia Maellaro; Mario Comporti; Lisa Pieri; Giorgio Minotti; Alfonso Pompella
Journal:  Biofactors       Date:  2003       Impact factor: 6.113

2.  A Rat Model of Oral Mucositis Induced by Cancer Chemotherapy for Quantitative Experiments.

Authors:  Issei Takeuchi; Riko Kawamata; Kimiko Makino
Journal:  Anticancer Res       Date:  2020-05       Impact factor: 2.480

3.  Mechanism for acivicin inactivation of triad glutamine amidotransferases.

Authors:  S V Chittur; T J Klem; C M Shafer; V J Davisson
Journal:  Biochemistry       Date:  2001-01-30       Impact factor: 3.162

4.  A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies.

Authors:  M Hidalgo; G Rodriguez; J G Kuhn; T Brown; G Weiss; J P MacGovren; D D Von Hoff; E K Rowinsky
Journal:  Clin Cancer Res       Date:  1998-11       Impact factor: 12.531

Review 5.  Use of a new adhesive film for the preparation of multi-purpose fresh-frozen sections from hard tissues, whole-animals, insects and plants.

Authors:  Tadafumi Kawamoto
Journal:  Arch Histol Cytol       Date:  2003-05

6.  Effect of Eriobotrya japonica seed extract on 5-fluorouracil-induced mucositis in hamsters.

Authors:  Daisuke Takuma; Sun Guangchen; Junko Yokota; Atsuhide Hamada; Masahide Onogawa; Saburo Yoshioka; Masahiko Kusunose; Mitsuhiko Miyamura; Syojiro Kyotani; Yutaka Nishioka
Journal:  Biol Pharm Bull       Date:  2008-02       Impact factor: 2.233

Review 7.  Is serum gamma-glutamyltransferase a marker of exposure to various environmental pollutants?

Authors:  Duk-Hee Lee; David R Jacobs
Journal:  Free Radic Res       Date:  2009-06

8.  Therapeutic Effect of GGsTop, Selective Gamma-glutamyl Transpeptidase Inhibitor, on a Mouse Model of 5-Fluorouracil-induced Oral Mucositis.

Authors:  Yosuke Shimamura; Issei Takeuchi; Hiroshi Terada; Kimiko Makino
Journal:  Anticancer Res       Date:  2019-01       Impact factor: 2.480

9.  Inhibiting Glutathione Metabolism in Lung Lining Fluid as a Strategy to Augment Antioxidant Defense.

Authors:  Martin Joyce-Brady; Jun Hiratake
Journal:  Curr Enzym Inhib       Date:  2011-07

10.  Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma.

Authors:  Marina Tuzova; Jyh-Chang Jean; Rebecca P Hughey; Lou Ann S Brown; William W Cruikshank; Jun Hiratake; Martin Joyce-Brady
Journal:  Front Pharmacol       Date:  2014-07-31       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.